The DOI matches its Crossref record.
Preparation of a Rabbit Anti-Guinea Pig Basophil Serum: in Vitro and in Vivo Characterization
Abstract
A high titer anti-basophil serum was prepared by immunizing rabbits with partially purified guinea pig peripheral blood basophils. Successive absorptions with normal guinea pig serum, red blood cells, polymorphonuclear leukocytes, and peritoneal-exudate macrophages and lymphocytes rendered the anti-basophil serum (ABS) reactive with basophils but no other leukocytes as determined by immunofluorescence, immunoferritin electron microscopy, and cytotoxicity assay. The basophil antigen(s) was expressed on the cell surface in close proximity to the plasma membrane and could be capped. ABS induced complement (C)-independent basophil degranulation and histamine release, but C was required for substantial basophil cytotoxicity and maximal degranulation and histamine release. ABS may recognize a basophil antigen(s) shared with tissue mast cells, because intradermal administration of small amounts of ABS produced local mast cell degranulation, reduction in skin histamine content, and an increase in vascular permeability that could be partially blocked by promethazine. ABS was tested in vivo in guinea pigs sensitized both with ovalbumin for cutaneous basophil hypersensitivity (CBH) and with mycobacteria for classic delayed hypersensitivity (DH). Administration of 0.25 to 1.0 ml of ABS i.v. reduced circulating basophils to 30% control values (p < 0.05) at 2 hr and reduced the number of bone marrow basophils to 7% control values (p < 0.001) at 24 hr. Other marrow and circulating leukocytes were not significantly affected. ABS also markedly reduced the number of basophils infiltrating 24-hr CBH reactions as determined by histology and histamine content. Other leukocytes were not altered nor was the cellular composition of DH or Con A-induced reactions affected. Systemic administration of ABS had no appreciable effect on subepidermal mast cells: the number and morphology of subepidermal mast cells, and the histamine content of normal skin were the same in animals that had received either i.v. ABS or NRS 24 hr before sacrifice. The CBH reactions in ABS-treated animals were more intensely erythematous than those in NRS-treated controls (p = 0.015). ABS may prove useful in analyzing the basophil's role in inflammatory reactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Administration of this ABS i.v. to guinea pigs sensitized to express “cutaneous basophil hypersensitivity” (CBH), an antigen-induced, delayed onset, erythematous skin reaction that contains large numbers of infiltrating basophils [44], revealed that ABS could be used to reduce markedly the numbers of basophils infiltrating the skin at such sites [43].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [43]
In the citing paper
“ABS did cause a reduction in skin mast cell numbers if injected intra-dermally, raising the possibility that the antiserum targeted an antigen shared by basophils and mast cells.”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [43]
In the citing paper
“Galli et al. generated a rabbit anti-guinea pig basophil antiserum (ABS) and showed that intravenous (i.v.) administration of ABS markedly reduced numbers of blood basophils in vivo, without reducing numbers of blood eosinophils or the total white blood cell count, or changing numbers of intradermal mast cells [43].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [43]
Citations
Cited by
Sorted by citations
Mast cells and IgE in defense against venoms: Possible “good side” of allergy?
Galli, S. J., Starkl, P., Marichal, T., & Tsai, M. (2016) · Allergology International · doi:10.1016/j.alit.2015.09.002 · Cited by 73
Self-citationMast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy
Galli, S. J., Metz, M., Starkl, P., Marichal, T., & Tsai, M. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00118-6 · Cited by 57
Self-citation
Metadata
- Authors
- Galli, S. J., Colvin, R. B., Verderber, E., Galli, A. S., Monahan, R., Dvorak, A. M., & Dvorak, H. F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1978-09-01
- Volume
- 121
- Issue
- 3
- Pages
- 1157-1166
- ISSN
- 0022-1767
- 1550-6606
- Cited by
- 15
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review